LED Medical Announces Canadian National Distribution Agreement with Sinclair Dental

LED Medical Diagnostics Inc. ("LED Medical, the Company")(TSX
VENTURE:LMD)(OTCQX:LEDIF)(FRANKFURT:LME) is pleased to announce that it has
entered into a partnership with Sinclair Dental ("Sinclair") for the
distribution of the VELscope Vx(R) Enhanced Oral Assessment System. 


"We are pleased to align ourselves with one of the fastest growing, full-service
dental supply companies in Canada to expand distribution of the VELscope Vx(R)
into more Canadian dental practices," commented David Gane, LED Medical's
President and CEO. "Sinclair has an experienced team of over 500 individuals
operating within 10 regional offices ready to represent our technology across
the country. We are impressed with Sinclair's leadership within the industry and
their responsiveness in bringing innovative solutions into the markets they
serve."


As the most powerful technology available for assisting in the discovery of oral
mucosal abnormalities, VELscope Vx(R) plays a key role in the early discovery of
such abnormalities, which can be critically important in the fight against oral
cancer. Detecting tissue abnormalities as early as possible is potentially
life-saving, and VELscope Vx(R) technology is proven effective and minimally
invasive and seamlessly can be implemented in a patient's routine dental
check-ups.


Ali Nowtash, Sinclair's Director, Marketing & Purchasing said, "We are pleased
to distribute the VELscope Vx system within the Canadian market. As the leader
in the discovery of oral mucosal abnormalities, LED Medical has created
significant awareness about oral cancer and the benefits of early diagnosis. We
share LED's commitment to the early detection of lesions and tissue
abnormalities and look forward to bringing this award-winning technology to our
clients." 


VELscope Vx(R)'s distinctive blue-spectrum light causes the soft tissues of the
mouth to naturally fluoresce. Healthy tissues fluoresce in distinct patterns
that are visibly disrupted by trauma or disease, such as neoplastic lesions,
chemical irritation, side-effects from medication, thermal damage, fungal, viral
or bacterial infections. Use of the VELscope Vx(R) allows a wide variety of oral
abnormalities to be discovered, often before they're visible to the unassisted
eye.


About Sinclair Dental

Proudly Canadian owned and operated, Sinclair is one of the fastest growing,
full-service dental suppliers in Canada. The company's expansion has not
compromised its tradition of quality products and exemplary service and it
continually strives to be an industry leader focused on customer satisfaction,
innovative solutions and being responsive to the industry's ever-changing trends
and needs. For more details, visit www.sinclairdental.com.


About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED
Medical Diagnostics Inc. is a leading developer of LED-based visualization
technologies for the medical industry. The Company is currently listed on the
Toronto Stock Exchange (TSX-V) under the symbol "LMD", the OTCQX under the
symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME".
For more information, visit www.ledmd.com.


Through its wholly-owned subsidiary, LED Dental Inc., the company manufactures
the VELscope(R) Vx Enhanced Oral Assessment System, the first system in the
world to apply tissue fluorescence visualization technology to the oral cavity.
VELscope(R) Vx devices are now used to conduct more screenings for oral cancer
and other oral diseases than any other adjunctive device. To date, there have
been more than 12,000 VELscope(R) Vx systems sold globally and they have been
used to perform more than 25 million exams. For more information, call
604.434.4614 or visit www.leddental.com.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Mark Komonoski, Investor Relations
LED Medical Diagnostics Inc. (TSX.V: LMD, FSE: LME)
[phone] or Toll-Free: [phone]
Cell: [phone]
[e-mail]
Skype: mkomonoski